Valuation: Zenotech Laboratories Limited

Market Cap 2.31B 24.22M 21.73M 20.09M 18.2M 34M 34.41M 240M 95.69M 1.21B 90.9M 88.98M 3.83B P/E 2025
56.5x
P/E 2026 -191x
Enterprise Value 2B 21.03M 18.87M 17.44M 15.8M 29.51M 29.87M 209M 83.07M 1.05B 78.91M 77.24M 3.33B EV / Sales 2025
7.42x
EV / Sales 2026 4.45x
Free-Float
15.47%
Yield 2025 *
-
Yield 2026 -
Oct. 28 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 CI
Jul. 28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
Apr. 29 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
Jan. 23 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
Jan. 23 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
25-10-31 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
25-07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-03-30 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
25-01-28 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
24-10-23 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
24-10-23 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
24-07-26 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
1 day+0.24%
1 week-4.08%
Current month-9.42%
1 month-10.87%
3 months-14.64%
6 months-16.78%
Current year-17.97%
1 week 36.86
Extreme 36.86
40.8
1 month 36.86
Extreme 36.86
44.25
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
54.14
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 2024-10-22
Director of Finance/CFO - 2014-02-05
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member 59 2015-07-07
Chairman 68 -
Director/Board Member 53 2020-01-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.24%-4.08%-27.69%-44.13% 24.22M
+0.50%+1.38%+57.09%+129.96% 1,148B
+0.86%+5.14%+45.00%+86.15% 652B
-0.14%+0.42%+25.69%+105.85% 505B
+0.41%+2.30%+54.03%+66.22% 384B
-0.63%-5.97%+61.93%+37.06% 348B
+2.06%+2.51%+34.13%+56.11% 294B
+0.85%-0.63%+2.69%+26.23% 264B
+0.87%+3.08%+54.69%+72.74% 244B
+0.08%+3.67%+35.05%+107.78% 197B
Average +0.51%+0.46%+34.26%+64.40% 403.72B
Weighted average by Cap. +0.51%+1.50%+44.88%+89.10%

Financials

2025 2026
Net sales 391M 4.11M 3.68M 3.41M 3.08M 5.76M 5.83M 40.71M 16.22M 205M 15.41M 15.08M 650M 402M 4.22M 3.78M 3.5M 3.17M 5.92M 5.99M 41.82M 16.66M 210M 15.82M 15.49M 667M
Net income 56.13M 589K 529K 489K 443K 827K 837K 5.84M 2.33M 29.37M 2.21M 2.16M 93.24M -10.72M -113K -101K -93.37K -84.57K -158K -160K -1.12M -445K -5.61M -422K -414K -17.81M
Net Debt -267M -2.8M -2.52M -2.33M -2.11M -3.94M -3.98M -27.81M -11.08M -140M -10.52M -10.3M -444M -304M -3.19M -2.87M -2.65M -2.4M -4.48M -4.54M -31.68M -12.62M -159M -11.99M -11.73M -505M
Projected Income Statement - Annual - Zenotech Laboratories Limited
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
264
Date Price Change Volume
26-10-29 ₹37.89 +0.24% 18,750
26-10-28 ₹37.80 -1.84% 6,651
26-10-27 ₹38.51 -1.28% 6,109
26-10-26 ₹39.01 -3.23% 8,930
26-10-23 ₹40.31 +2.05% 3,902
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock